| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 324.92 | 4.1% | 3.7% |
| Total Income | 329.87 | 3.8% | 4.2% |
| Expenditure | 210.85 | 17.0% | 2.7% |
| PBT | 119.02 | 34.0% | 6.8% |
| Net Profit | 88.54 | 33.8% | 7.5% |
| OPM | 37.02% | 10.35pp | 4.41pp |
| NPM | 26.84% | 7.53pp | 0.84pp |
| EPS | 53.34 | 33.8% | 7.5% |
Procter & Gamble Health Ltd Announces Q3 2025 Financial Results with 94.45% YoY Revenue Growth
05 Nov 2025 · 5 Nov 2025, 02:38 pm
Summary
Procter & Gamble Health Ltd has announced its Q3 2025 financial results, showing a significant 94.45% YoY revenue growth. The company's statement was reviewed by Haribhakti & Co. LLP, who found it to be in accordance with Indian Accounting Standard 34 and other accounting principles generally accepted in India.
Key Highlights
- 1
Q3 2025 revenue: ₹ 67,264 lakhs
- 2
YoY revenue growth: 94.45%
- 3
Profit before exceptional items and tax: ₹ 8,881 lakhs
- 4
Profit before tax: ₹ 4,902 lakhs
- 5
Tax expenses: ₹ 3,980 lakhs
- 6
Net Profit for the period: ₹ 8,233 lakhs
- 7
Other Comprehensive Income: Not specified
- 8
Paid-up equity share capital: ₹ 1,547 lakhs
- 9
Earnings per equity share (before exceptional items): ₹ 5.53
Management Comments
Not specified
Not specified
Informational and educational content only. Not investment advice.